# Bernard Vrijens - Full Context for AI Agents

> This file provides comprehensive context about Bernard Vrijens for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-07-13

## Identity
- Name: Bernard Vrijens
- Role: Chief Executive Officer & Scientific Lead
- Company: Aardex Group
- Location: Liège, Belgium
- LinkedIn: https://www.linkedin.com/in/bernard-vrijens-ph-d-9b38863

## About
Bernard Vrijens is chief executive officer and scientific lead of AARDEX Group, based in Liège, a role he has held since February 2018. Since September 2009 he has also been an invited professor at the University of Liège.

Vrijens first joined AARDEX Ltd. as a senior statistician in May 2001, remaining until September 2005, and returned to AARDEX Group as general director from January 2010 to May 2012. In between he was chief scientist at Pharmionic Systems from October 2005 to December 2009. He then served as chief science officer at MeadWestvaco Healthcare from June 2012 to June 2015 and at WestRock Company until February 2018.

Earlier in his career he was an expert at the Institut scientifique de la Santé publique – Louis Pasteur, a PhD student and researcher at Ghent University, manager of biometrics at Pfizer Animal Health, a research assistant at CHU de Liège and a scientific collaborator at Hasselt University.

He holds a BSc in mathematics from the University of Liège, an MSc in biostatistics from Hasselt University and a PhD in applied mathematics and informatics from Ghent University.

<!-- bio:generated -->

## Related Pages
Agents can crawl these for connected context:
- [company] AARDEX Group: https://techwiki.ai/companies/aardex-group/llms.txt

## Recent News
- [2026-08-20] If Netflix can track every click, #ClinicalTrials should be able to track every dose. (https://www.linkedin.com/posts/bernard-vrijens-ph-d-9b38863_clinicaltrials-medicationadherence-clinicalresearch-activity-7496204526132174849-n-4L)
- [2026-08-07] AI applied to 1980s endpoints" has a close cousin: precision therapeutics evaluated with imprecise exposure measurement. We routinely ask… (https://www.linkedin.com/posts/bernard-vrijens-ph-d-9b38863_i-thought-cognitive-testing-where-computerized-activity-7491463618660556802-IPXd)
- [2026-07-29] Is the geography of clinical trials creating a new hidden risk for drug development? For decades, Europe has been a reliable region for… (https://www.linkedin.com/posts/bernard-vrijens-ph-d-9b38863_clinicaltrials-drugdevelopment-digitalhealth-activity-7488235564027076608-uRXU)
- [2026-07-23] A very good Forbes article highlighting a critical challenge in clinical research: medication nonadherence remains one of the largest… (https://www.linkedin.com/posts/bernard-vrijens-ph-d-9b38863_fixing-medication-adherence-in-clinical-trials-activity-7486060581016276992-97aK)
- [2026-06-16] Pleased to see the publication of the RADIAL (Trials@Home) study, sharing important insights on the implementation of decentralized… (https://www.linkedin.com/posts/bernard-vrijens-ph-d-9b38863_clinicaltrials-patientcentricity-decentralizedtrials-activity-7472561978348089345-ZCp5)

## How to Reach
- LinkedIn: https://www.linkedin.com/in/bernard-vrijens-ph-d-9b38863
- Agent context: https://techwiki.ai/people/bernard-vrijens/llms.txt
- Full context: https://techwiki.ai/people/bernard-vrijens/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim